CD82 and breast carcinoma: A direct correlation of overall patients’ survival and KAI1 expression had been observed in at least the following five solid tumors: colorectal carcinoma, gastric carcinoma, non-small cell lung cancer (NSCLC), breast cancer, and laryngeal squamous cell carcinoma (LSCC), reviewed in6.